Next Article in Journal
Plasma Thymidine Kinase Activity as a Novel Biomarker in Metastatic Melanoma Patients Treated with Immune Checkpoint Inhibitors
Previous Article in Journal
Potential Involvement of NSD1, KRT24 and ACACA in the Genetic Predisposition to Colorectal Cancer
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Cancers
Volume 14
Issue 3
10.3390/cancers14030703
Review Report
cancers-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Article
Peer-Review Record

Direct Oral Anticoagulants Are Associated with Superior Survival Outcomes than Warfarin in Patients with Head and Neck Cancers

Cancers 2022, 14(3), 703; https://doi.org/10.3390/cancers14030703
by Chien-Lin Lee 1,†, Wei-Shan Chen 2,†, Yinshen Wee 3, Ching-Shuen Wang 4, Wei-Chih Chen 2, Tai-Jan Chiu 5,6, Yu-Ming Wang 7, Ching-Nung Wu 2, Yao-Hsu Yang 8,9,10, Sheng-Dean Luo 2,6,* and Shao-Chun Wu 6,11,*
Reviewer 1:
Sheng-Po Hao
Reviewer 2: Anonymous
Cancers 2022, 14(3), 703; https://doi.org/10.3390/cancers14030703
Submission received: 26 December 2021 / Revised: 26 January 2022 / Accepted: 28 January 2022 / Published: 29 January 2022

Round 1

Reviewer 1 Report

This is a retrospective cohort study on a group of selected head and neck cancer patients between 2001 and 2019 in one major cancer center in Taiwan. The authors analyzed and compared the survival rate among users of three different categories of anticoagulants: DOACS, warfarin, and none and found a significant survival benefit on DOACS users than warfarin and none.

There are some major concerns:

  1. there is no clear description on the selection criteria of three different anticoagulant group, including the duration, frequency, etc of the usage of three different anticoagulants.
  2. there is no explanation on the possible mechanism that DOACS is better than warfarin in users' survival.

    There are some minor concerns:

    1. Please check English spelling, grammar and flow.

Author Response

Please see the attachment.

Author Response File: Author Response.docx

Reviewer 2 Report

Introduction

In order to improve the literature reported on this subject, it would be interesting to discuss this remarkable systematic review. cite doi: 10.1002/14651858.CD006650.pub5.

Methods

  • the strobe guidelines were performed?
  • in the figure 1 all the abbreviations need to be added in the captation

Results

  • Table I add also the SD for age and other values
  • AJCC stage, calculate the p value for each class and add a symbol

Discussion

  • line 242,  before drawing conclusions it would be better to insert the data reported in the literature as prospective or randomized studies, meta-analyzes, and then report its data. cite doi:10.1182/blood.2020005819.
  • line 256, although head and neck squamous carcinoma is mainly related to viral phenotype or smoking alcohol other important indices in the patient's prognosis are locoregional or distant metastases, with interesting parameters such as lymph node ratio. cite doi:10.1016/j.anl.2021.05.007.
  • line 264, it should be interesting to describe different survivals according to the different DOAC available

Author Response

Please see the attachment.

Author Response File: Author Response.docx

Round 2

Reviewer 1 Report

Accept as it is.

Author Response

We thank the reviewer again for valuable comments and the acceptance of our manuscript.  

Back to TopTop